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Abstract
Background: Knowledge translation (KT) platforms are organisations, initiatives and networks that focus on
supporting evidence-informed policy-making at least in part about the health-system arrangements that determine
whether the right programmes, services and products get to those who need them. Many descriptions and
evaluations of KT platforms in low- and middle-income countries have been produced but, to date, they have not
been systematically reviewed.
Methods: We identified potentially relevant studies through a search of five electronic databases and a variety of
approaches to identify grey literature. We used four criteria to select eligible empirical studies. We extracted data
about seven characteristics of included studies and about key findings. We used explicit criteria to assess study
quality. In synthesising the findings, we gave greater attention to themes that emerged from multiple studies,
higher-quality studies and different contexts.
Results: Country was the most common jurisdictional focus of KT platforms, EVIPNet the most common name and
high turnover among staff a common infrastructural feature. Evidence briefs and deliberative dialogues were the
activities/outputs that were the most extensively studied and viewed as helpful, while rapid evidence services were
the next most studied but only in a single jurisdiction. None of the summative evaluations used a pre–post design
or a control group and, with the exception of the evaluations of the influence of briefs and dialogues on intentions
to act, none of the evaluations achieved a high quality score.
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Conclusions: A large and growing volume of research evidence suggests that KT platforms offer promise in
supporting evidence-informed policy-making in low- and middle-income countries. KT platforms should consider as
next steps expanding their current, relatively limited portfolio of activities and outputs, building bridges to
complementary groups, and planning for evaluations that examine ‘what works’ for ‘what types of issues’ in ‘what
types of contexts’.
Keywords: Knowledge translation, Evidence-informed policy, Health systems, Systematic evaluation
Background
Evidence-informed policy-making
Our definition of evidence-informed policy-making has
two parts. The first part involves using the best available
data and research evidence – systematically and trans-
parently – in the time available in each of the four
phases of the policy-making process [1], namely (1)
prioritising problems and understanding their causes
(i.e. agenda-setting); (2) deciding which option to pursue
(i.e. policy or programme development); (3) ensuring
that the chosen option makes an optimal impact at ac-
ceptable cost (i.e. policy or programme implementation);
and (4) monitoring implementation and evaluating im-
pact. The second part of the definition involves recognis-
ing that the data and research evidence will be used
alongside the institutional constraints, interest-group
pressure, citizen values and other sources of ideas that
influence the policy-making process (i.e. policy-making
takes place within a political context) [1]. A democratic-
ally elected politician typically wants to know that there
is a compelling problem (with well understood causes)
and a viable policy or programme option (with signifi-
cant benefits, minimal-to-no harms and acceptable
costs), and that the political climate is right, before tak-
ing action [2, 3]. The politician’s advisors may also want
to know about implementation, monitoring and evalu-
ation plans [3].
The organisations, initiatives and networks supporting
evidence-informed health policy-making can be differen-
tiated, based on previous works by the authors, accord-
ing to which phase(s) of the policy-making process they
focus on and whether that focus is about: (1) clinical
programmes, services and products (e.g. prescription
drugs) that target individuals; (2) public health pro-
grammes and services that target groups and popula-
tions; and/or (3) health system (i.e. governance, financial
and delivery) arrangements that determine whether the
right programmes, services and products get to those
who need them, in ways that improve population health
and the patient or citizen experience, while keeping per
capita costs manageable [4, 5].
Consider the following six examples, which comple-
ment the type of organisation that is the focus of this
study, described in greater detail in the next section [6]:
 most data-analytics organisations focus on (1) un-
derstanding policy problems and possibly monitor-
ing implementation and (2) clinical or public health
topics;
 most clinical practice guideline initiatives focus on
(1) informing which programmes, services and
products clinicians should provide (i.e. policy or
programme development) and (2) clinical practices;
 most health technology assessment (HTA) networks
focus on (1) informing which programmes, services
and products a health system should provide and (2)
clinical and, less commonly, public health
‘technologies’;
 most modelling organisations focus on (1)
estimating the expected reach and impact of
selected practices/technologies and related financial,
human, and other resource needs and (2) practices/
technologies and, less commonly, health system
arrangements;
 most implementation research/behavioural insights
initiatives focus on (1) informing which
implementation approach a health system should
use to improve the reach and impact of selected
practices/technologies and (2) health system
arrangements; and
 most evaluation networks focus on (1)
understanding the impact of selected policy choices
(e.g. practices/technologies) and (2) clinical or public
health topics.
Knowledge translation (KT) platforms
Our focus here is what we call KT platforms, which we
define as organisations, initiatives and networks that
focus on supporting evidence-informed policy-making at
least in part about the governance, financial and delivery
arrangements that determine whether the right pro-
grammes, services and products get to those who need
them (i.e. supporting the use of research evidence in
health systems policy-making) [7–9]. While not a part of
our formal definition (or, as we describe in the Methods
section, not part of our eligibility criteria), these KT plat-
forms also typically (1) focus on three of the four phases
of the policy-making process (i.e. clarifying problems,
framing options and identifying implementation
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considerations), as opposed to prioritising a single phase;
(2) use existing data analyses and existing systematic re-
views of the available research evidence when possible
(much like guideline initiatives and HTA networks), as
opposed to conducting new data analyses, modelling ex-
ercises, implementation studies or impact evaluations;
(3) use a broad range of approaches to making available
and supporting the use of the best available data and re-
search evidence, often alongside systematically elicited
insights from policy-makers and stakeholders (and
values from citizens, less commonly) and on timelines of
hours and days to weeks and months, as opposed to a
single approach, with evidence only and on timelines of
years; and (4) consider their success in terms of inform-
ing the policy-making process as opposed to securing
peer-reviewed grants and publishing peer-reviewed pa-
pers [7–9].
Our focus is specifically KT platforms in low- and
middle-income countries (LMICs), where policy-making
in over-burdened and under-resourced health systems
may present particular challenges, including [10, 11] (1)
institutional constraints, such as colonialism-related
policy legacies (e.g. weak state capacity for using key
policy instruments and for policy implementation,
weak civil society groups) and informal institutions
(e.g. ‘big-man presidentialism’); (2) unique forms of
interest-group pressure, such as external donors (and
arguably international organisations and other bodies
influenced by these donors), multi-national firms (e.g.
natural resource companies) and ethnocultural (e.g.
tribal) groups as well as public sector corruption in
some countries; (3) limitations in the availability and
reliability of key sources of ideas, such as local data
and research, and media coverage; and (4) influences
external to the health sector such as limited global
market for low-cost technologies.
While our interest in KT platforms arose from our in-
volvement in the WHO-sponsored Evidence-Informed
Policy Networks (EVIPNet) or in similar entities seen as
peers to EVIPNet [8, 12, 13], our focus is not limited to
any particular type of organisation, initiative or network.
Moreover we have not constrained ourselves to particu-
lar health or political system contexts (e.g. national
health services with centralised policy authority,
multi-party political systems); infrastructures (e.g.
whether the group is ‘embedded’ within a ministry of
health or located in a university or other independent
body, minimum team size and diverse composition);
approaches (e.g. building demand for data and evi-
dence and the capacity to find and use them, pack-
aging data and evidence and ‘pushing’ it to those who
need it); or measures of outcomes and impact (e.g.
more policy-relevant research evidence available, spe-
cific measures of evidence use).
Describing and evaluating KT platforms
Describing and evaluating KT platforms becomes in-
creasingly difficult as one moves from (1) description
through formative evaluation and on to summative
evaluation and (2) activities and outputs (i.e. the ap-
proaches used) through outcomes and impacts (i.e.
whether the approaches are making a difference) and on
to context and infrastructure (i.e. whether the health and
political system context and the KT platform’s infra-
structure influence what approaches are used and
whether these approaches translate into outcomes and
impact).
When it comes to summative evaluation, for example,
the KT field continues to search for the ‘holy grail’ of
outcome and impact measures that are light touch and
can be applied across both ‘intervention’ and ‘control’
groups [14]. The gold standard is widely understood to
be multiple case studies examining the influence of an
approach or suite of approaches on policy decisions
using key-informant interviews, documentary analyses
and media analyses that, together, can (1) disentangle in-
strumental (i.e. direct) uses of research evidence and
conceptual uses of research evidence (i.e. changing
thinking about a problem or option) from political uses
of research evidence (i.e. ‘after the fact’ use of research
evidence to justify a choice made for other reasons); (2)
rule out confounding influences (i.e. competing vari-
ables); and (3) address attribution (i.e. the role played by
the approach or the KT platform more generally) [10,
11]. When it comes to evaluating whether and how con-
text and infrastructure affect such relationships, one im-
mediately comes up hard against a sample-size challenge
— finding enough health and political system contexts
(i.e. unitary states or sub-national jurisdictions in federal
states) and infrastructures (i.e. organisational design)
supporting a common approach that can be evaluated
and willing to use a common evaluation method [15].
Many descriptions and evaluations of KT platforms in
LMICs have been produced but, to date, they have not
been systematically reviewed. The objective of this sys-
tematic review is to describe the findings of empirical
studies that (1) describe the activities and outputs of KT
platforms; (2) formatively evaluate these activities and
outputs; (3) summatively evaluate whether activities and
outputs achieve outcomes and impacts; (4) describe the
KT platforms’ context and infrastructure; and (5) exam-
ine other types of linkages among variables (which we
call ‘linkage evaluations’), such as (a) context and infra-
structure influencing whether activities and outputs
achieve outcomes and impacts; (b) context influencing
decisions about infrastructure design, activities and out-
puts selected, or the baseline measure of key outcomes;
and (c) infrastructure influencing decisions about activ-
ities and outputs selected. We provide an illustration of
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these variables and their potential inter-relationships in
Fig. 1, using (1) the Cochrane KT framework to organise
findings about activities and outputs [16]; (2) the EVIP
Net Monitoring and Evaluation Framework to illustrate
(but not limit) the potential outcomes [18]; (3) the
Health Systems Evidence framework (governance, fi-
nancial and delivery arrangements) to organise find-
ings about health-system contexts and about the KT
platform’s infrastructure [17]; and (4) the 3I+E frame-
work (institutions, interests, ideas and external fac-
tors) to organise findings about political system
contexts [10, 11].
Methods
We used the Preferred Items for the Reporting of Sys-
tematic Review and Meta-Analysis (PRISMA) statement
to guide the design of the systematic review [19]. We
did not require approval from a research ethics board to
conduct the review and no external funding was drawn
upon to support this review. Several members of the re-
search team are actively involved in operating, support-
ing and evaluating KT platforms; however, and as noted
below, we took steps to ensure that these team members
were not involved in the execution of several key steps
in the review.
Identifying potentially relevant studies
We began developing our search parameters by identify-
ing synonyms for three conceptual domains relevant to
our review question (and combining synonyms within a
domain with ‘OR’ and then across domains with ‘AND’),
namely knowledge translation, policy-making and
LMICs (which we addressed using a filter developed by
the Norwegian satellite of Cochrane’s Effective Practice
and Organisation of Care review group in 2012) [20].
We did not include restrictions for language or date but
we did apply limits for three keywords (antibiotic, cancer
and treatment) that yielded many clinically focused stud-
ies that were not relevant. We then worked with a health
sciences librarian at McMaster University to iteratively
improve our search parameters in light of the perform-
ance of our searches, including whether they were iden-
tifying a set of articles that we anticipated would meet
our eligibility criteria. Finally, we adjusted the search pa-
rameters to each electronic database as needed. We pro-
vide the search string for MEDLINE in Additional file 1
as an illustration of our search parameters.
We conducted searches in five electronic databases,
namely Cumulative Index to Nursing and Allied Health
(CINAHL), Embase, Global Health, MEDLINE and Web
of Science. Searches were conducted on two separate oc-
casions, first in January 2015 (week 2) and again in Sep-
tember 2016 (week 4) to capture studies published in
the intervening time period. We complemented the elec-
tronic database searches with a variety of approaches to
identify additional literature (including grey literature),
namely requests for studies sent to experts in the field;
manual review of the reference lists of included studies;
‘related articles’ search in PubMed for all included stud-
ies (in July 2017); and manual review of a list of studies
published by EVIPNet affiliates, whether or not EVIPNet
was the focus of the evaluation, that was maintained by
Fig. 1 Illustration of the variables and their potential inter-relationships [10, 11, 16–18]
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the study authors as part of their evaluation work (also
in July 2017).
Selecting eligible studies
We used four criteria to assess eligibility for inclusion in
the review: (1) does the article discuss (a) organisations,
initiatives or networks located in or targeted at (b)
LMICs whose goal is at least in part to (c) support the
use of research evidence in health systems policy-
making?; (2) does the article have a methods section?;
(3) does the article report empirical data based on the
application of these methods?; and (4) do the empirical
data pertain to context, infrastructure, activities/outputs,
outcomes and/or impacts of these organisations, initia-
tives and networks?
All criteria needed to be met in order to be included
in the systematic review. We did not exclude articles
using specific exclusion criteria such as studies in non-
peer-reviewed publications (i.e. what is sometimes called
grey literature).
We assessed eligibility in three phases: (1) title and ab-
stract review, which was completed by one reviewer
(ACRP) on the full sample and by a second reviewer
(HR) on a 20% sample; (2) first full-text article review,
which was again completed by one reviewer (ACRP) on
the full sample and by a second reviewer (HR) on a 20%
sample; and (3) a second full-text article review, which
was completed by three reviewers (ACRP, HR and JNL)
on all articles that were short-listed for inclusion (i.e.
that made it through the first full-text article review), to
ensure that criteria 1 and 4, which were the most diffi-
cult to judge, were appropriately assessed. Any dis-
agreements that arose among the reviewers were
resolved by consensus. We calculated the agreement
between reviewers on the two 20% samples using
Fleiss’ Kappa coefficient. The Fleiss’ Kappa coefficient
on the two 20% samples were 0.66 and 0.71, respect-
ively. We retained a list of ‘near miss’ papers that
were excluded in case a reader wanted to double-
check the application of our inclusion criteria. These
are available in Additional file 2.
Extracting data from studies
We extracted data about the following characteristics of
included studies: (1) lead author, year and citation; (2)
jurisdictional focus of KT platform(s); (3) name(s) of KT
platform(s); (4) categories of variables and/or relation-
ships addressed (i.e. descriptive findings, formative eval-
uations, summative evaluations and linkages evaluations
about KT platforms’ context, infrastructure, activities
and outputs, outcomes, and impacts); (5) time period
studied; (6) data collection method(s) used; and (7) ob-
jective(s). We also extracted the key findings from in-
cluded studies, with a focus on the variables and
relationships described above (e.g. findings about activ-
ities and outputs were extracted and organised using the
Cochrane KT framework subheadings). When more than
one article described the same empirical study, we
treated them as a single study for data-extraction pur-
poses only if the same data were re-presented across ar-
ticles. After extensive pilot testing, data were extracted
by one reviewer who was not involved in any of the
studied KT platforms (ACRP). A second reviewer (CM)
checked all extracted data and resolved any concerns
through discussion with the first reviewer.
Assessing the quality of studies
For all included studies, we used the following explicit
criteria to assess quality, with a focus on those including
a formative and/or summative evaluation: (1) two or
more data collection methods were used (because cor-
roboration across multiple information sources enhances
the credibility of studies of policy-making, where there
can be incentives to reporting or documenting the ra-
tionale for a decision in a particular manner) [21, 22];
(2) a random or purposive sampling strategy was
employed (because jurisdictions, cases, key informants
and documents must either be representative of the
study population from which they are drawn or, in the
case of qualitative research, their selection must be well
reasoned) [21]; (3) the response rate was greater than
60% (because higher response rates suggest that samples
– of key informants, for example – are not biased); (4)
two or more types of evidence use were examined (be-
cause studies that do not distinguish among instrumen-
tal, conceptual and tactical uses of research evidence are
likely to miss or conflate politically important differences
in how research evidence is used); and (5) two or more
competing variables were examined (because studies that
fail to examine factors like institutional constraints and
interest-group pressure are likely to misrepresent the
factors that influence the use of research evidence in
policy-making) [10].
We used the first three criteria to assess descriptive
studies and formative evaluations (yielding a score out of
three) and all five criteria to assess summative evalua-
tions that measured impact (yielding a score out of five).
We did not use more traditional risk-of-bias criteria (e.g.
random sequence generation, blinding of participants
and personnel) to assess the summative evaluations be-
cause none of the included studies used formal effective-
ness designs such as a randomised controlled trial. We
specified cases where scores for individual formative,
summative and/or linkage evaluations were different
from overall study scores. Articles were deemed to be
high quality if they received a score of at least two points
if they were assessed using the first three criteria or at
least three points if they were assessed using all five
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criteria. After extensive pilot testing, quality was assessed
by one reviewer who is involved with a KT platform but
not one that has yet been studied (CM) and was checked
by a second reviewer (ACRP). Discrepancies were resolved
through discussion between the reviewers and any conflicts
were reviewed and resolved with a third reviewer (JNL).
Synthesising the findings
In synthesising the findings, we gave greater attention to
themes that emerged from (1) multiple studies, (2)
higher-quality studies and (3) different contexts. The
first draft of the synthesis was completed by one re-
viewer who was not involved in any of the studied KT
platforms (ACRP) and the second and final drafts were
completed in conjunction with a second reviewer (JNL).
Results
As illustrated in Fig. 2 (PRISMA flow diagram), we began
with 5526 potentially relevant articles from our first
search, 7867 articles from our second search and eight ar-
ticles from other sources. We included 38 articles after
completing all phases of the eligibility assessment [23–60].
We provide, in Additional file 2, the citations for ‘near
miss’ papers that were excluded, which appear in the form
of two lists: 41 were identified as part of the first full-text
article review (and were a subset of the 180 articles ex-
cluded at this stage) of the results from both searches (and
by one reviewer) and 28 were identified as part of the sec-
ond full-text article review of the results from both
searches (and by three reviewers). Given that we consider
the second list to be true ‘near misses’, we only report
these ones in the PRISMA flow diagram.
Fig. 2 PRISMA flow diagram
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Characteristics of included studies
Based on our analysis of the characteristics of included
studies provided in Additional file 3, we note the follow-
ing patterns:
 the years of publication ranged from 2008 to 2017,
with the median year of publication being 2014;
 the most common jurisdictional focus of the KT
platforms was country rather than sub-national, re-
gional (supra-national) or global, while the most
common country focus was Uganda (appearing in
13 studies) [23, 24, 33, 41–48, 52, 53], Lebanon
(appearing in 8 studies, of which 6 examine Lebanon
in the context of the Eastern Mediterranean region)
[28–32, 34, 41, 59], and South Africa (appearing in 8
studies) [23, 24, 26, 37, 42, 49, 51, 54];
 the most common name used by the KT platforms
was EVIPNet (appearing in 17 studies) [25, 28–33,
37, 41, 44–48, 50, 52, 53], whether because that was
the formal name of the group or because it
considered itself part of the EVIPNet ‘family’ even if
it went by a different name, such as REACH Policy
Initiative Uganda and its variously named rapid
evidence service (e.g. Makerere University’s service,
REACH Policy Initiative service, SURE project
service or rapid response service);
 the most common variables and relationships
addressed, were as follows:
descriptions (n = 33 of 38 studies) [23–38, 40–
43, 46–49, 51–56, 58–60] were more common
than formative evaluations (n = 18) [23, 27, 33, 36,
37, 43–47, 50, 52, 54, 55, 57–60], summative
evaluations (n = 15) [24, 33, 36, 43, 46, 47, 50–56,
58, 59], or studies of other linkages among
variables (n = 4) [23, 33, 36, 45];
of the descriptive studies, context (n = 24 of 33
studies) [24–26, 28–38, 40–43, 48, 49, 52–54, 56]
was the most common focus, followed by
activities/outputs (n = 17) [26, 27, 33, 36, 38, 40,
43, 46, 47, 51, 52, 54–56, 58–60] and
infrastructure (n = 14) [23, 24, 26, 27, 33, 37, 38,
40, 46, 52, 54–56, 59];
of the formative evaluations, evidence briefs (n
= 8 of 18 studies) [33, 43, 44, 47, 52, 55, 57, 59]
and deliberative dialogues (n = 6) [33, 47, 52, 55,
57, 59] were the most common activities and
outputs examined;
of the summative evaluations,
deliberative dialogues were the most common
activities examined (n = 4 of 15 studies) [33, 47,
55, 59];
of the studies of other linkages among variables,
the relationships between context and activities and
outputs (n = 3 of 4 studies) [33, 36, 45] as well as
infrastructure and activities and outputs (n = 3) [23,
33, 45] were most commonly examined, followed by
context and infrastructure (n = 1) [23];
 the time period studied ranged from 1996 to 2015,
with the median year of time period studied (if
ranges were given, the value in the middle of the
range) being 2010; and
 the most common data collection methods used
were interviews (n = 20 of 38 studies) [23, 24, 26,
27, 33–38, 42, 44–46, 49, 51, 54, 58–60], surveys (n
= 17) [27, 28, 30–32, 34, 40, 42, 43, 46, 47, 50–52,
56, 57, 59] and case studies involving multiple
methods (n = 4) [54, 56, 59, 60] (there were 12
articles studying only one case [35, 43–46, 48, 54,
56–60] and only 4 of them used more than one data
collection method).
Turning now to the quality assessments for studies in-
cluding a formative and/or summative evaluation, which
we present in Additional file 4 alongside quality assess-
ments for all included studies, we offer the following
summary:
 for formative evaluations, the mean and median
quality scores were 1.0 and 1.0 out of 3, respectively,
and the most common criterion responsible for a
lower score was a response rate lower than 60%; and
 for summative evaluations, the mean and median
quality scores were 1.3 and 1.0, respectively, but this
time out of 5, and the most common criterion
responsible for a lower score was two or more types
of competing variables examined.
Summary of findings
Finally, we turn to the summary of findings from in-
cluded studies (which we present in detail in Add-
itional file 5). Beginning this summary with descriptions
of the more frequently mentioned activities and outputs
(Table 1), we found that:
 evidence briefs and deliberative dialogues were the
activities/outputs that have been the most
extensively studied and the most widely undertaken
(both in numbers, with the exception of rapid
syntheses in some countries, and in different
contexts); and
 rapid evidence services and capacity-building work-
shops (specifically those focused on evidence use be-
cause these are the ones that seek to directly
influence the use of research evidence in policy-
making) were arguably the next most extensively
studied and widely undertaken (if not counting
‘other evidence outputs’ that appear likely to be pro-
duced by KT platform staff but are not as central to
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Table 1 Findings from descriptions of activities and outputs*









Building demand No studies identified NA NA NA
Prioritisation and co-
production
Priority-setting exercises for activities and outputs
• Four studies described KT platforms conducting priority-setting exer-
cises involving policy-makers, stakeholders and researchers but the
numbers were unclear and the formats were not described in detail
[26, 33, 52, 59] – 1.5/3, 2/5, 1.5/3, 2.5/5, respectively
Yes (4) Yes (1) NA
Packaging, push, and support
to implementation
Evidence briefs
• Nine studies described KT platforms producing evidence briefs [24, 27,
33, 47, 52, 54, 55, 58, 59] – 1.5/5, 1.5/3, 2/5, 3/5, 1.5/3, 2.5/5, 1/5, 0/3, 2.5/
5, respectively
Across these nine studies, 24 unique KT platforms operating in 15
unique countries produced 63 evidence briefs (with double-counting
possible across studies and some studies not providing numbers)
Six of the nine studies described briefs that met EVIPNet (or
SURE) criteria or were produced with support from EVIPNet (or SURE)
Yes (9) No Yes (15)
Other evidence outputs
• Systematic reviews
Four studies described KT platforms producing systematic reviews
[24, 33, 38, 40], although the data from two studies include high-
income countries and could not be disaggregated – 1.5/5, 2/5, 2/3,
2/3, respectively
Considering only the data from the two studies focused on
LMICs, only 3 KT platforms (each in a separate country) produced
systematic reviews and then only infrequently [24, 33] – 1.5/5, 2/5,
respectively
• Traditional research outputs
Seven studies described KT platforms producing traditional
research outputs [24, 26, 27, 33, 38, 40, 54], although again the data
from two studies include high-income countries and could not be
disaggregated – 1.5/5, 1.5/3, 1.5/3, 2/5, 2/3, 2/3, 2.5/5, respectively
These outputs include articles in peer-reviewed journals [24, 26,
27, 33, 54] – 1.5/5, 1.5/3, 1.5/3, 2/5, 2.5/5, respectively, research reports
[24, 26, 27, 54] – 1.5/5, 1.5/3, 1.5/3, 2.5/5, respectively, policy-relevant
research in various formats [24] – 1.5/5, and conference presentations
[54] – 2.5/5
No (2 or 5) Yes (2 and 2) No (3 or
NA)
Facilitating pull Online clearinghouses
• Four studies described KT platforms developing online clearinghouses
[33, 40, 52, 55] – 2/5, 2/3, 1.5/3, 1/5, respectively, although the data from
one study include high-income countries and could not be disaggre-
gated [30] – 2/3
Two studies described KT platforms developing clearinghouses,
with the one in Uganda (REACH Policy Initiative Uganda) focused on
health policy and systems research from that country (Uganda; 2012)
[52] – 1.5/3 and the one in Cameroon (EVIPNet Cameroon) focused
on health policy and systems research as well as evidence briefs and
syntheses (Cameroon; 2009) [52, 55] – 1.5/3, 1/5, respectively
One study described five KT platforms as being in the process of
creating online clearinghouses [33] – 2/5
No (3) Yes (1) No (2)
Rapid evidence services
• Four studies described KT platforms implementing rapid evidence
services [33, 46, 52, 60] – 2/5, 1/5, 1.5/3, 1/3, respectively
Across these four studies, four KT platforms (each in a separate
country) were operating such services, including REACH Policy
Initiative Uganda, EVIPNet Burkina Faso, EVIPNet Cameroon and
ZAMFOHR
REACH Policy Initiative Uganda received 65 evidence requests
from 30 policy-makers and stakeholders in the first 28 months,
returned 82% of responses on time [46] – 1/5 and it produced 73
briefs in the 2010–2012 period [52] – 1.5/3
EVIPNet Burkina Faso delivered five rapid syntheses to four
national-level policy-makers during its experimental phase (March–
Yes (4) No No (3 or
4)
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their goal of supporting evidence-informed policy-
making).
The evidence briefs (sometimes called ‘evidence briefs
for policy’) described in the included studies are a
jurisdiction-specific summary of what is known from local
data and studies and from systematic reviews about (1) a
problem and its causes, (2) options for addressing it and
(3) key implementation considerations. The deliberative
dialogues (sometimes called ‘policy dialogues’ or ‘stake-
holder dialogues’) involve a diverse group of policy-
makers, stakeholders and researchers – informed by a
pre-circulated evidence brief – deliberating about the
same three topics as well as next steps for different con-
stituencies, with the key themes captured in a dialogue
summary. The combination of the evidence brief and dia-
logue summary are intended to provide policy-makers
with the best available research evidence and systematic-
ally elicited stakeholder insights. The rapid evidence ser-
vices described in the included studies provide a summary
of what is known, typically from systematic reviews and
sometimes from local data and studies, and from jurisdic-
tional scans. These are typically in time frames of days to
weeks and about one of a problem, policy options, or im-
plementation considerations. The capacity-building work-
shops are intended to help policy-makers and
stakeholders to find and use research evidence on their
own as part of a systematic approach to examining prior-
ity issues, whether they have minutes, hours or days to in-
form a policy-making process. The systematic approach
Table 1 Findings from descriptions of activities and outputs* (Continued)









December 2011) [60] – 1/3
Using three of the same studies, the three named KT platforms
appear to have produced 99 rapid syntheses [46, 52, 60] – 1/5, 1.5/3,
1/3
Building capacity to use (and support the use of) research evidence
• Three studies described at least five KT platforms based in four
different countries that conducted capacity-building workshops for
policy-makers and other evidence users in the areas of using research
evidence, engaging in evidence-informed policy-making and undertak-
ing KT activities [24, 33, 55] – 1.5/5, 2/5, 1/5, respectively
Two additional studies [38, 40] – 2/3, 2/3, respectively, described
numerous KT platforms that conducted capacity-building workshops,
but these studies include high-income countries and could not be
disaggregated
• Three studies described 12 KT platforms based in 11 different
countries that conducted internal capacity-building workshops for KT
platform staff about various KT activities and outputs [33, 54, 58] – 2/5,
2.5/5, 0/3, respectively, with 10 focused on preparing evidence briefs
[33], three focused on conducting systematic reviews and undertaking
priority-setting exercises [33], and two on KT activities in general [54,
58]
• Three studies described four KT platforms based in three different
countries that conducted 37 capacity-building workshops for a broad
range of groups – policy-makers, stakeholders and researchers – in the
area of KT activities [52, 55, 56] – 1.5/3, 1/5, 2.5/3, respectively
No for use (3) No No for
use (4)
Exchange Deliberative dialogues
• Eight studies described KT platforms convening deliberative dialogues
[24, 27, 33, 47, 52, 55, 58, 59] – 1.5/5, 1.5/3, 2/5, 3/5, 1.5/3, 1/5, 0/3, 2.5/5,
respectively
Across these eight studies, 20 KT platforms in 15 different
countries convened 45 deliberative dialogues (with double-counting
possible across studies and some studies not providing numbers)
Seven of the eight studies described dialogues that were
informed by a pre-circulated evidence brief (while the other did not
specify this)
Six of the eight studies described dialogues that met EVIPNet (or
SURE) criteria or were convened with support from EVIPNet (or SURE)
Yes (8) Yes (1) Yes (15)
EVIPNet Evidence-Informed Policy Networks, KT knowledge translation, NA not available, REACH Regional East African Community Health, SURE Supporting the Use
of Research Evidence, ZAMFOHR Zambia Forum for Health Research
*Supporting studies for each finding are cited, and quality scores for each supporting study are presented in italicized text
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Table 2 Findings from formative evaluations of activities and outputs*









Building demand Awareness raising
• One study found that increasing awareness among policy-makers,
stakeholders and researchers about the importance of initiatives to sup-
port evidence-informed policy-making was regarded as an organisa-
tional strength across seven KT platforms [33] – 2/5 (formative score 1/3)
No (1) No Yes (7)
Prioritisation and co-
production
Priority-setting exercises for activities and outputs
• One study found that prioritising operational research was
consistently regarded as an organisational strength across three KT
platforms, with one each operating in South Africa, Thailand and
Uganda [37] – 2.5/3 (formative score 2/3)
No (1) Yes (1) No (3)
Packaging, push, and support
to implementation
Evidence briefs
• Six studies examined EVIPNet-style evidence briefs [33, 47, 52, 55, 57,
59] – 2/5 (formative score 1/3), 3/5 (formative score 2/3), 1.5/3, 1/5, 2/3,
2.5/5, respectively
Four studies found that they are highly regarded by policy-
makers and stakeholders in Bangladesh, Nigeria and Zambia [33, 47,
55, 57], with the highest-quality study finding that EVIPNet-style evi-
dence briefs were highly rated by policy-makers and stakeholders in
Burkina Faso, Cameroon, Ethiopia, Nigeria, Uganda and Zambia –
both in terms of whether they achieved their objective and in terms
of their key design features – regardless of country, group or issue in-
volved [47]
Two studies found that some readers struggled with them not
concluding with recommendations [47, 52] while one study found
that respondents’ self-reported professional roles being other than
‘policy-maker’ or ‘stakeholder’ was a significant predictor of giving a
lower helpfulness score to evidence briefs not concluding with rec-
ommendations [47]
One study found that the graded-entry format of briefs is viewed
a very favourable element [59]
Yes (6) Yes (2) No (3)
Facilitating pull Rapid evidence services
• Four studies examined the rapid evidence service in Uganda [44–46,
60] – 1/5, 1.5/3, 1/3, 1/3 (formative score 0/3), respectively
One study found that key success factors for such services include
awareness of user needs (i.e. consultation with policy-makers), the
opportunity for feedback from users (i.e. being a personalised service)
and working within current norms and behaviours of users [46]
A second study identified regular contact between policy-makers
and researchers (i.e. service staff) as a key factor in the uptake of, and
response to, the service [45]
Two studies found that the rapid syntheses produced by these
services are perceived as a desirable and user-friendly output by
policy-makers and stakeholders [44, 46]
One study found identified as favourable aspects of rapid
syntheses their policy relevance and right time frame for production
[60]
Another study identified as aspects of rapid syntheses not always
meeting expectations, the speed by which they were produced/
delivered, their quality, the degree of contextualisation [60] and the
absence of recommendations [44]
Yes (4) No No (1)
Building capacity to use (and support the use of) research evidence
• Two studies examined training programmes for health policy advisory
committee members to improve their use of research evidence in
policy-making but neither identified explicitly the key findings from a
formative evaluation [27, 58] – 1.5/3 (formative score 1/3), 0/3,
respectively
One study described two 5-day training workshops that included
sessions focused on the role of knowledge brokers, research method-
ology and writing, and impact evaluation [27]
A second study described both a 1-day training workshop on evi-
dence briefs, deliberative dialogues and priority-setting, and a 3-
month training programme focused on enhancing capacity for
No (2) No No (1
and 1)
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maps policy questions about problems, options and imple-
mentation considerations onto types of research evidence
and then those types of research evidence onto appropri-
ate sources of pre-appraised, synthesised research evi-
dence (such as Health Systems Evidence).
Moving on to formative evaluations of activities and
outputs (Table 2), we found that:
 evidence briefs and deliberative dialogues were the
activities/outputs that have been the most
extensively studied and the most widely viewed as
helpful both in general and in terms of the specific
design features commonly used by EVIPNet; and
 rapid evidence services were the next most
extensively studied but only in a single jurisdiction
(Uganda).
These formative evaluations took the form of surveys
administered to participants in deliberative dialogues,
with one survey about the pre-circulated evidence brief
being completed before the dialogue began and a second
survey about the dialogue itself after the dialogue was
completed.
Continuing on to the summative evaluations of out-
comes and impacts (Table 3), we found that:
 KT platforms as a whole have been the most
extensively studied in terms of both (1) impacts on
policy-making processes and (2) influence on out-
comes such as stronger relationships between
policy-makers and researchers and raising awareness
about, and building demand for, using research evi-
dence; and
 evidence briefs and deliberative dialogues were the
next most extensively studied, both in terms of their
Table 2 Findings from formative evaluations of activities and outputs* (Continued)









research, evidence-informed policy-making and health policy advo-
cacy, leadership development in resource-limited areas, and health
policy monitoring, evaluation and performance assessment [58]
Exchange Deliberative dialogues
• Six studies examined deliberative dialogues informed by evidence
briefs and found them to be highly regarded as a tool for enhancing
evidence-informed policy-making [33, 47, 52, 55, 57, 59] – 2/5 (formative
score 1/3), 3/5 (formative score 2/3), 1.5/3, 1/5, 2/3, 2.5/5, respectively
The highest-quality study found that EVIPNet-style deliberative di-
alogues were highly rated by policy-makers and stakeholders in Bur-
kina Faso, Cameroon, Ethiopia, Nigeria, Uganda and Zambia – both
in terms of whether they achieved their objective and in terms of
their key design features – regardless of country, group or issue in-
volved [47]
The same study found that participants without past research
experience were more likely to associate ‘not aiming for consensus’
with a lower rating of the helpfulness of the dialogues [47]
Yes (6) Yes (2) No (3)
Research-to-policy workshops
• Two studies examined research-to-policy workshops and found that
they were perceived to have helped promote improved/new opportun-
ities for collaboration and networks, increased/new knowledge, policy
brief writing skills, and an enhanced understanding of the importance
of research and evidence-based decision-making [43, 50] – 1/3, 1/5,
respectively
One study held four successive workshops focused on research
evidence and its policy implications, hands-on skills and policy brief
writing, and presentation of policy briefs [43]
Another study found that participants in a 3-day international
forum on evidence-informed policy-making (1) identified four areas
for improvement – smaller programme to accommodate more time
for discussions; clearer meeting objectives; further exploration of
evidence-informed policy-making initiative sustainability; and inclu-
sion of training on writing policy briefs; and (2) highlighted presenta-
tions on country experiences and impact evaluation/analysis sessions
as the most enjoyable [50]
No (2) No No (2)
EVIPNet Evidence-Informed Policy Networks, KT knowledge translation
*Supporting studies for each finding are cited, and quality scores for each supporting study are presented in italicized text; instances where scores for individual
formative evaluations differ from overall study scores are specified
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Table 3 Findings from summative evaluations of outcomes and impact*











• Ten studies reported a total of 23 KT platforms conducting
activities and outputs that collectively led to some direct
impacts on select policy-making processes, although the num-
ber of policy-making processes influenced and the nature of
these impacts were often not described [24, 33, 36, 46, 47, 51,
53–55, 59] – 1.5/5, 2/5, 1.5/5, 1/5, 3/5, 2/5, 1/4, 2.5/5, 1/5, 2.5/5,
respectively
Yes (10) Yes (1) Yes (23)
Evidence briefs and deliberative dialogues
• Four studies examined EVIPNet-style evidence briefs and
deliberative dialogues [33, 47, 55, 59], – 2/5, 3/5, 1/5, 2.5/5,
respectively, and found that they:
led to strong intentions to act among dialogue
participants in Burkina Faso, Cameroon, Ethiopia, Nigeria,
Uganda and Zambia [47]
had direct impacts on select policy-making processes in
Bangladesh and Cameroon (both for evidence briefs alone
and the combination of briefs and dialogues) and in nine
countries with active KT platforms (for the combination of
briefs and dialogues) [33, 47, 55, 59]
• One study found that policy briefs different from EVIPNet-
style evidence briefs led to direct impacts on select policy-
making processes in South Africa [54] – 2.5/5
Yes (4) Yes (1) Yes (12)
Other activities and outputs
• Other studies that examined activities and outputs that led to
direct impacts on select policy-making processes focused on
rapid evidence services/rapid syntheses [46] – 1/5, research
publications [24, 54] – 1.5/5, 2.5/5, respectively, participation in
government meetings [24] – 1.5/5, translation and appraisal of
research findings [36] – 1.5/5, and research-to-policy meetings




No No for any
given activity/
output
Outcomes – More policy-relevant
research evidence available
Project-outcomes evaluation (as an activity)
• One study examined the influence of an activity on this
outcome and found that 73% of individuals involved in project
outcome evaluation in Bangladesh believed that the project
increased access to research evidence [55] – 1/5
KT platforms
• One study examined the influence of two KT platforms on a
range of outcomes related to policy-relevant research evidence
being available (e.g. more funding for monitoring and evalu-
ation) [53] – 1/4





• Three studies examined the influence of KT platforms on this
outcome:
eight KT platforms reported strengthened relationships
among policy-makers, stakeholders, researchers [33] – 2/5
one KT platform reported new spaces for deliberations
on priority health policy issues having been created through
a network of local and global factors and agents [52] – 1.5/3
another KT platform reported that relationships among
policy-makers, stakeholders and researchers were strength-
ened as a result of a deliberative dialogue organised by the
KT platform, with future meetings and workshops held inde-
pendently to discuss implementation as an example of such
strengthening [59] – 2.5/5
Project outcome evaluation (as an activity)
• The same study from Bangladesh reported above found that
73% of individuals involved in project outcome evaluation
believed that the project cemented relationships between
policy-makers and researchers [55] – 1/5
No (3 or 1) No Yes (8+ for KT
platforms)
Outcomes – Greater policy-
maker capacity to use research
Workshops and other forms of training
• Four studies examined the influence of workshops and other
No for any
given form
No No for any
given form
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impact on policy-makers’ and stakeholders’ inten-
tions to act on what was learned and on select
policy-making processes.
However, none of these summative evaluations used a
pre–post design or a control group and, with the excep-
tion of the evaluations of the influence of briefs and dia-
logues on intentions to act [47], none of the evaluations
achieved a high quality score. The scores presented in
Table 3 are the overall study scores and the scores for
individual summative findings are always the same or
even lower (these more detailed results are available
within Additional files 3 and 5).
With respect to context and infrastructure (Table 4),
we found:
 many descriptions of the political system context in
which the KT platforms are operating, some
descriptions of their research system context and no
descriptions of their health-system context;
 some descriptions of the KT platforms’
infrastructure; and
 no formative evaluations of the KT platforms’
context or infrastructure per se, just statements
made in single studies about helpful aspects of the
context or infrastructure (which their designs did
not permit them to examine rigorously).
The key features of the political and research system con-
text in which the KT platforms are operating (specifically
those identified in four or more studies) include (1) policy-
makers have limited capacity for finding and using research
Table 3 Findings from summative evaluations of outcomes and impact* (Continued)








evidence forms of training on this outcome:
one study found that workshops honed policy brief
writing skills, increased scientific knowledge and networks
with researchers, and increased awareness of the importance
of research and evidence-based decision-making [43] – 1/3
a second study found that an international forum with a
partial focus on capacity-building led less than half of partici-
pants to report new skills as a benefit overall (46%) but one-
fifth (19%) reported an intent to utilise new skills [50] – 1/5
a third study found that a workshop improved
participants’ knowledge, understanding of policy-making
and use of evidence [56] – 2.5/3
a fourth study found that training future policy-makers
was a key contributor to their policy influence success [54] –
2.5/5
‘Buddy’ programme that pairs policy-makers and researchers
• One study found that Policy BUDDIES (Policy BUilding
Demand for evidence in Decision-making through Interaction
and Enhancing Skills) enhanced the capacity of subnational
policy-makers to ask for, demand and use systematic review
evidence (and other products of evidence syntheses) to inform
policy-making [36] – 1.5/5
Advisory committee
• One study found that a Health Policy Advisory Committee
improved knowledge about evidence-to-policy links, KT and
operationalisation of KT amongst Health Policy Advisory Com-
mittee members as well as their capacity to find and use evi-
dence [58] – 0/3
Outcomes – Other (awareness
and demand)
KT platforms
• Two studies examined the influence of KT platforms on other
outcomes:
seven KT platforms reported they have increased
awareness of the importance of initiatives supporting
evidence-informed policy-making [33] – 2/5
six KT platforms reported higher policy-maker demand
for KT products [33] – 2/5
one KT platform reported greater awareness of and
demand for KT tools amongst policy-makers, stakeholders
and researchers as a result of a deliberative dialogue orga-
nised by the KT platform [59] – 2.5/5
No (2) No Yes (7)
KT knowledge translation
*Supporting studies for each finding are cited, and quality scores for each supporting study are presented in italicized text
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Table 4 Findings from descriptions of context and infrastructure*








Context – Health system No studies identified key features of the governance,
financial and delivery arrangements of the health system
where KT platforms are operating
NA NA NA
Context – Political system where
KT platforms are operating
Institutions
• Five studies identified that policy legacies have left
policy-makers with limited capacity for finding and
using research evidence in policy-making [28, 32, 35,
36, 49] – 2/3, 1/3, 0.5/3, 1.5/5, 1.5/3, respectively, and
while one study identified a willingness among policy-
makers to build their capacity [49] – 1.5/3, another
study found that policy-makers rarely participate in
such activities [28] – 2/3
• Four studies identified that policy-making processes
have many veto points where key interests can block
evidence-informed policy proposals or support com-
peting alternatives [28, 31, 32, 49] – 2/3, 1/3, 1/3, 2.5/3,
respectively, of which two studies indicated that this
can be further complicated when there is public sector
corruption [28, 32] – 2/3, 1/3, respectively
• Three studies identified a lack of administrative
structures supporting evidence-informed policy-
making processes [31, 32, 49] – 1/3, 1/3, 2.5/3, respect-
ively, and three studies identified a more general lack
of dedicated government budgets for research and for
supporting evidence-informed policy-making, particu-
larly at national and regional levels [32, 37, 54] – 1/3,
2.5/5, 2.5/3, respectively
Interests
• Two studies identified that select stakeholders – mid-
level policy-makers, donors, universities and media –
were particularly important in supporting evidence use
[42, 43] – 1.5/3, 1/3, respectively
Ideas
• Three studies identified that policy-makers do not
value research evidence as a source of ideas for policy-
making [32, 37, 49] – 1/3, 2.5/3, 1.5/3, respectively,
while three other studies identified that a political cli-
mate in which research evidence is valued could sup-
port knowledge translation [26] – 1.3/3, and influence
the development and evolution of KT platforms [52,
54] – 1.5/3, 2.5/5, respectively
External factors (i.e. factors external to the health sector)
• Two studies identified that the frequent turnover of
top-level policy-makers hinders efforts to support
evidence-informed policy-making [28, 30] – 2/3, 1/3,
respectively
• One study found extremely limited media coverage
of health-systems research evidence and/or systematic
reviews [25] – 1/2











Context – Research system
where KT platforms are
operating
Evidence availability
• Three studies identified small but growing
production of health policy and systems research
being produced [29, 34, 48] – 1/2, 1/3, 0.5/2,
respectively, particularly in the areas of delivery
arrangements and implementation strategies [29, 48]
or financial arrangements [48]
• One study identified that research evidence is
perceived as unavailable or, more specifically, to be
lacking on priority topics or (when it is available) hard
for policy-makers to access, poorly timed in relation to
policy-making processes or not applicable to local con-
texts [49] – 1.5/3
Evidence synthesis capacity
• Two studies identified little evidence synthesis
Yes (4 for one)
but no for rest
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Table 4 Findings from descriptions of context and infrastructure* (Continued)








capacity [41, 53] – 1/3, 1/4, respectively, particularly in
the area of health systems as opposed to clinical care
or public health [41]
Researcher engagement in KT
• Four studies identified low levels of researcher
engagement in supporting evidence-informed policy-
making [28–30, 56] – 2/3, 1/2, 1/3, 2.5/3, respectively
Research funding agency support for KT
• One study found that most funding agencies include
KT in their mandate (18 or 23), but only about one-
third of funding agencies prioritise KT (8 of 23) and
they allocate less than 20% of their budget to KT, and
that national funding agencies give greater attention
to KT than international agencies [26] – 1.5/3
Infrastructure – KT platform
governance arrangements
Decision-making authority
• Six studies identified the variability in whether
decision-making authority for the KT platform was lo-
cated in government or elsewhere, with several KT
platforms operating as units within ministries of health
or as units subject in other ways to ministry oversight
(e.g. in a government hospital), while other KT plat-
forms operated in academic institutions, private organi-
sations and other settings, sometimes with governing
boards having varying degrees of independence and
at other times having no dedicated governance mech-
anism [23, 24, 33, 40, 52, 60] – 1.5/3, 1.5/5, 2/5, 2/3, 1.5/
3, 1/3, respectively
Networks/multi-institutional arrangements
• Three studies identified variability in whether KT
platform created (or identified the need to create) a
formal infrastructure to convene policy-makers, stake-
holders and researchers or established informal con-
tacts with these groups [24, 55, 56] – 1.5/5, 1/5, 2.5/3,
respectively, and while one study identified that strong
linkages between KT platforms and policy-makers were
very important for KT activities [24] – 1.5/5, another
study identified that these linkages could introduce
conflicts of interest and be considered an organisa-
tional weakness [37] – 2.5/3
• Two studies identified that KT platforms benefited
significantly from the support of EVIPNet, both through
south–south collaborations (e.g. focused on rapid
evidence services) or north–south collaborations (e.g.
EVIPNet Cameroon, REACH Policy Initiative Uganda)
[52, 60] – 1.5/3, 1/3, respectively
• One study found that most KT platforms did the
work themselves ‘in house’, while some commissioned
work externally [38] – 2/3
Yes (6 for one)
but no for rest




Infrastructure – KT platform
financial arrangements
Funding
• Four studies identified that short-term, unpredictable
or scarce ongoing funding alongside high operating
costs are major barriers to KT platform activities and
sustainability [23, 33, 37, 54] – 1.5/3, 2/5, 2.5/3, 2.5/5, re-
spectively, one study identified that financial inde-
pendence facilitated effective policy engagement [24]
– 1.5/5, and one study identified that many KT plat-
forms do not have clear fundraising strategies [23] –
1.5/3
• Three studies identified that most KT platforms
received money from funding agencies, donors or
government to initiate and scale up their work [23, 52,
60] – 1.5/3, 1.5/3, 1/3, respectively
• One study identified that budgets varied widely in
size (e.g. US$26,000 for the Health Policy Analysis Unit
Yes (4 for one)
but no for rest
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evidence in policy-making; (2) policy-making processes
have many veto points where key interests can block
evidence-informed policy proposals or support competing
alternatives; and (3) there are low levels of researcher en-
gagement in supporting evidence-informed policy-making.
The key features of the KT platform’s infrastructure (again
those identified in four or more studies) include (1)
variability in whether decision-making authority for the KT
platform was located in government or elsewhere; (2)
short-term, unpredictable or scarce ongoing funding; (3) a
lack of skilled human resources to draw upon; and (4) high
turnover among KT platform staff. Examples of the state-
ments made about helpful aspects of KT platforms’ context
and infrastructure include (1) high-level political support is
Table 4 Findings from descriptions of context and infrastructure* (Continued)








in Uganda in 2008 to US$1,300,000 for the Health
Strategy and Policy Institute in Vietnam in 2007) [23] –
1.5/3, while another study found that costs were
higher during early phases (awareness,
experimentation and expansion phases) that were
funded externally and then lower during the
consolidation phase that is funded by the government
[60] – 1/3
Infrastructure – KT platform
delivery arrangements
Human resources
• Four studies identified a lack of skilled human
resources to draw upon as a key organisational
weakness [23, 33, 37, 54] – 1.5/3, 2/5, 2.5/3, 2.5/5,
respectively, and a fifth identified that earlier successes
led to increased demand from policy-makers and
stakeholders, which was difficult to meet because of
the lack of skilled KT platform staff [60] – 1/3
• Four studies identified high turnover among KT
platform staff [23, 33, 52, 54] – 1.5/3, 2/5, 1.5/3, 2.5/5,
respectively, with one study noting that once staff
develop the necessary skills they frequently move to
better paid positions elsewhere [23] – 1.5/3
• Three studies identified the range in number of KT
platform staff, with one being the lower end, 50 the
higher end, and many with five or fewer full-time
equivalent staff [23, 38, 40] – 1.5/3, 2/3, 2/3, respectively
• Two studies identified the breadth in backgrounds of
KT platform staff (e.g. medical or social/population
studies, research methods training, policy analysis and
writing skills, and understanding of health systems and
policy-making processes) [23, 46] – 1.5/3, 1/5,
respectively
• One study identified the importance of KT platform
leaders, particularly in facilitating links with policy-
makers and stakeholders [55] – 1/5
Scope
• Two studies identified variability in the scope of KT
platforms, with some focusing on one or two phases
of the policy-making process (e.g. Policy BUDDIES
programme in Cameroon and South Africa, respect-
ively), some focusing on specific topic areas (e.g. public
health or primary care), and some supporting policy-
making about clinical practice (through guidelines) or
technologies (through health technology assessments)
as well as policy-making about health systems [36, 40]
– 1.5/5, 2/3, respectively
Phase of development
• One study identified key phases in the process of
institutionalising a rapid evidence service, the different
needs in different phases, and how changes within
(e.g. staffing) and beyond (e.g. changes in the home
directorate) the KT platform can affect the
institutionalisation process [60] – 1/3
Yes (4 for two)
but no for rest







EVIPNet Evidence-Informed Policy Networks, KT knowledge translation, NA not available
*Supporting studies for each finding are cited, and quality scores for each supporting study are presented in italicized text
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key; (2) ‘home-grown’ models can have a greater likelihood
of success; (3) strong, independent advisory or governance
structures are helpful; and (4) staff who are well trained and
proactive are essential.
Concluding with other types of linkages among vari-
ables, we found only four studies [23, 33, 36, 45] that ex-
amined such linkages (Table 5) and they suggest that
political support (context) and networks/multi-institu-
tional arrangements (infrastructure) can influence the de-
mand for, and supply of, activities and outputs.
Discussion
Principal findings
Although it remains premature to make definitive
statements about whether KT platforms in general or
their particular approaches are effective, let alone
whether and how context and infrastructure influence
whether the approaches translate into outcomes and
impact, we have a large and growing volume of re-
search evidence (38 studies) suggesting that KT plat-
forms offer promise in supporting evidence-informed
policy-making in LMICs. Our principal findings in-
clude the following:
 country was the most common jurisdictional focus
of the KT platforms and EVIPNet the most
common name used by them;
 descriptions (33 of 38 studies) were more common
than formative evaluations (18, of which 8 were about
evidence briefs and 6 about deliberative dialogues),
Table 5 Findings from studies that examine other types of linkages among variables*










No studies identified NA NA NA
Context affects: activities/
outputs ➔ outcomes
No studies identified NA NA NA
Infrastructure affects: activities/
outputs ➔ impacts
No studies identified NA NA NA
Infrastructure affects: activities/
outputs ➔ outcomes
No studies identified NA NA NA
Context ➔ infrastructure Financial sustainability
• One study found that political transitions
and institutional rivalry emerged as barriers





Context ➔ activities/outputs Political support
• Two studies found that political support increased
awareness and the perceived legitimacy of a KT platform
and thereby the demand for (and then supply of) its
activities and outputs (e.g. rapid syntheses) [33, 45]
– 2/5, 1/3, respectively
External factors
• One study found that external factors limited the ability
of one KT platform in Cameroon to link policy-makers
and researchers effectively, in this case due to a poliomyelitis










• Two studies found that networks/multi-institutional
arrangements involving the KT platform and governments,
stakeholder organisations, research organisations (both
within and outside the KT platform’s country) and/or
funding agencies increased awareness of the KT platform,
provided reminders to draw on it, and developed its capacity
to respond with appropriate activities and outputs
[33, 45] – 2/5, 1/3, respectively
• One study examining three KT platforms found
that linking KT platforms with policy-makers and forming
external networks with research organisations allowed KT






KT knowledge translation, NA not available
*Supporting studies for each finding are cited, and quality scores for each supporting study are presented in italicized text
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summative evaluations (17, of which 4 were about
deliberative dialogues) or studies of other linkages
among variables (4);
 interviews and surveys were the most common data
collection methods used (20 and 17 of 38 studies,
respectively);
 quality scores were generally low for both formative
and summative evaluations;
 evidence briefs and deliberative dialogues were the
activities/outputs that have been the most widely
undertaken (both in numbers, with the exception of
rapid syntheses in some countries and in different
contexts), with rapid evidence services and capacity-
building workshops the next most common;
 evidence briefs and deliberative dialogues were also
the activities/outputs that have been the most
extensively subjected to formative evaluation and the
most widely viewed as helpful both in general and in
terms of the specific design features commonly used
by EVIPNet, while rapid evidence services were the
next most extensively studied but only in a single
jurisdiction (Uganda);
 KT platforms as a whole, followed by evidence briefs
and deliberative dialogues, have been the most
extensively subjected to summative evaluation;
however, none of these summative evaluations used
a pre–post design or a control group and, with the
exception of the evaluations of the influence of
briefs and dialogues on intentions to act, none of the
evaluations achieved a high quality score;
 the key features of the political and research system
context in which the KT platforms are operating
(specifically those identified in four or more studies)
include (1) policy-makers have limited capacity for
finding and using research evidence in policy-making;
(2) policy-making processes have many veto points
where key interests can block evidence-informed pol-
icy proposals or support competing alternatives; and
(3) there are low levels of researcher engagement in
supporting evidence-informed policy-making;
 the key features of the KT platform’s infrastructure
include (1) variability in whether decision-making
authority for the KT platform was located in govern-
ment or elsewhere; (2) short-term, unpredictable or
scarce ongoing funding; (3) a lack of skilled human
resources to draw upon; and (4) high turnover
among KT platform staff; and
 the four studies examining linkages among other
variables found that political support (context) and
networks/multi-institutional arrangements
(infrastructure) can influence the demand for, and
supply of, activities and outputs.
Strengths and limitations
Our systematic review has five main strengths, as fol-
lows: (1) we conducted an exhaustive, broad-based
search for both published and grey literature; (2) we
used explicit criteria to set a relatively low threshold for
inclusion (and one that did not privilege certain types of
KT platforms, health or political system contexts, infra-
structures, approaches, or measures of outcomes and
impact) and provided reassurance about reliability when
only one reviewer was involved in their application (e.g.
ensuring we had achieved an acceptable Kappa statistic);
(3) we used explicit quality criteria that reflected best
practices in studies of policy-making processes (e.g. two
or more data collection methods used, two or more
types of evidence use examined, and two or more com-
peting variables examined); (4) we gave greater attention
to themes that emerged from multiple studies, higher-
quality studies, and different contexts; and (5) we took
steps to ensure that team members who are involved in
operating, supporting and evaluating KT platforms were
not involved in several key steps in the review (and to
provide data in this review that would allow other, more
fully independent researchers to re-examine the data).
There are three main weaknesses in our review, two of
which have more to do with the difficulties of describing
and evaluating KT platforms than they do with the de-
sign and execution of the review, namely (1) study
searches were undertaken in 2015 and 2016 and the re-
lated articles search in 2017; (2) none of the summative
evaluations used formal effectiveness designs, such as a
randomised controlled trial (and hence we did not use
traditional risk-of-bias criteria), likely in no small part
because of the lack of outcome and impact measures
that can reliably perform as well as of case studies focus-
ing on untangling actual influences on policy-making
that often take place over long periods of time, behind
‘closed doors’, and in other ways that make simple met-
rics difficult to apply; and (3) the near absence of studies
of linkages among variables highlights the sample-size
challenge of finding enough contexts and infrastructures
supporting a common approach that can be evaluated
using standardised methods.
Findings in relation to other studies
To the best of our knowledge, this is the first systematic
review of descriptions and evaluations of KT platforms
in LMICs. The ever-growing number of systematic re-
views undertaken to inform efforts to support evidence-
informed policy-making [61–64] differ in important
ways from what has been studied in the current evalu-
ation – some examine the factors associated with the
use of research evidence in policy-making, with findings
from well over 100 observational studies suggesting that
several key factors (such as timing/timeliness,
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interactions between policy-makers and researchers, and
an accordance between policy-makers’ beliefs, values,
and strategies, and the available research evidence) are
associated with greater prospects for evidence use (and
most KT platforms’ portfolio of activities and outputs
address these factors directly); some examine the effect-
iveness of specific approaches to supporting evidence-
informed policy-making, yet the two highest-quality re-
views both found only a single effectiveness study (and it
was focused on public health, not health systems); and
many involve an ill-defined hybrid between these two,
do not distinguish between policy-making about clinical,
public health and health-systems topics, and do not give
attention to best practices in studies of policy-making
processes.
Implications for policy and practice
We offer three implications of our review for those creat-
ing, leading or supporting KT platforms: (1) consider
expanding the current, relatively limited portfolio of activ-
ities and outputs (e.g. to include citizen panels that can
bring systematically elicited citizens’ values to the table
alongside research evidence in the form of evidence briefs
and stakeholder insights derived from deliberative dia-
logues, as several high-income country KT platforms are
now doing); (2) consider aligning with evaluation initia-
tives using a common approach to outcomes and impact
measurement to facilitate cross-platform learning (as
EVIPNet did in its first decade); and (3) consider giving
greater attention to context (especially how to adjust infra-
structure and activities and outputs to respond to unique
political and health system contexts) and to infrastructure
(especially how to institutionalise the KT platform in ways
that minimise disruptions as governments change, exter-
nal funding priorities shift and charismatic leaders are
drawn into new domains), particularly given that this re-
view suggests that the prospects for robust empirical an-
swers to these questions are limited.
While not implications arising from this review per se,
this work did prompt us to reflect on where KT plat-
forms may need to move in future, as follows (1) con-
sider building bridges to organisations, initiatives and
networks working in complementary areas such as
guideline and HTA units (that also rely on existing data
and evidence) but also data-analytics, modelling, imple-
mentation research and evaluation units (that are build-
ing data and evidence de novo to support a particular
phase of the policy-making process); (2) consider part-
nering with allies both within government (such as min-
isterial advisory bodies and parliamentary research
offices) and outside government (such as the WHO col-
laborating centres and WHO country offices that also
support policy-making processes, and the WHO guid-
ance panels that produce global health-systems guidance
that needs country-level activities and outputs like evi-
dence briefs and deliberative dialogues to be contextua-
lised in order to achieve impacts); (3) consider what can
be done to institutionalise the use of research evidence
in policy-making processes (e.g. requiring brief descrip-
tions of how research evidence was used to clarify a
problem, frame options and identify implementation
considerations, and simple checklists of which sources of
pre-appraised synthesised research evidence were
searched and what types of evidence were found); and
(4) consider collaborating with organisations, networks
and initiatives that are operating in the broader Sustain-
able Development Goals space but that have not had the
long-term focus on supporting evidence-informed
policy-making that has been a hallmark of the health
sector (particularly now that the beta version of Social
Systems Evidence is available as a source of pre-
appraised synthesised research evidence) across all Sus-
tainable Development Goals except the three about the
environment (climate, land and water).
Implications for future research
While we are in urgent need of a monitoring and evalu-
ation plan 2.0 for KT platforms, our experience with the
KT platform monitoring and evaluation plan 1.0 used
for EVIPNet and now with this review reinforce for us
how very difficult it will be to design one that is sensitive
both to best practices in studies of policy-making pro-
cesses and to best practices in summative evaluations
(i.e. effectiveness studies). The paradox is that KT plat-
forms attempt to hold others to account to use research
evidence in their decision-making, yet they themselves
work in a space that is so difficult to evaluate in robust
ways.
Conclusions
A large and growing volume of research evidence sug-
gests that KT platforms offer promise in supporting
evidence-informed policy-making in LMICs. While our
review had many strengths, many of which reflect best
practices in studies of policy-making processes, unfortu-
nately, none of the summative evaluations used formal
effectiveness designs, which limits our ability to make
statements about ‘what works’. KT platforms should
consider as next steps expanding their current, relatively
limited portfolio of activities and outputs (e.g. to include
citizen panels), building bridges to complementary
groups (e.g. data-analytics organisations supporting the
problem-clarification phase of the policy-making
process), and planning for evaluations that examine
‘what works’ for ‘what types of issues’ in ‘what types of
contexts’.
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